Express Diagnostics history

2016

  • August: Patent for DrugCheck® SalivaScan (assaying analytes in bodily fluids) approved by the United States Patent Office
  • February: Production begins at Express Diagnostics Global, Ltd. in Sofia, Bulgaria
  • January: DrugCheck® screening devices receive endorsement of the National Narcotic Officers' Associations Coalition

2015

  • October: Announces formation of Express Diagnostics Global – Bulgaria
  • September: DrugCheck® screening devices receive endorsement of the California Narcotic Officers' Association
  • August: For the third consecutive year, named to the Inc. 5000 list of fastest-growing companies in the U.S.

2014

  • November: Patent for DrugCheck® SalivaScan approved by the European Patent Office
  • October: Express Diagnostics Int'l celebrates 10th anniversary
  • August: Named to the Inc. 5000 list of fastest-growing companies in the U.S. for the second year in a row

2013

  • December: Number of countries in which Express Diagnostics-manufactured products are distributed exceeds 60 for the first time
  • August: Express Diagnostics listed on the Inc. 5000 list of fastest-growing companies in the U.S.
  • June: Acquisition of ArcFlow technology from Eveia, Inc.
  • April: DrugCheck® NxStep OnSite cup receives Health Canada Class III license allowing use of the device in near-patient settings, such as physicians’ offices

2012

  • November: AnemiaCheck POC Quantitative Hematocrit device named a top 10 finisher in the LifeScience Alley New Technology Showcase
  • August: Dedicated Express Diagnostics representative hired to service Europe, Middle East, and Africa (EMEA); based out of Strasbourg, France
  • July: First to market with a urinalysis test for gamma-hydroxybutyric acid (GHB)
  • February: First to market with a urinalysis test for K2 / synthetic cannabis

2011

  • March: Introduces DrugCheck® SalivaScan Oral Fluid Drug Test, the first saliva drug test with a sponge saturation indicator; patent pending in U.S, E.U.

2010

  • January: Launches DrugCheck® Waive line of drug screening devices for CLIA-waived testing facilities

2009

  • June: Agreement signed with Australian distributor granting exclusive rights to distribute DrugCheck® product throughout Australia and New Zealand

2008

  • September: Launches DrugCheck® Online Management System (OMS), providing customers with web-based self-directed training and test results management capability
  • March: Introduces DrugCheck® NxScan flat-panel cup

2007

  • July: Begins offering private-label manufacturing of screening devices
  • June: First to market with a urinalysis test for alcohol

2005

  • September: Implements in-house manufacturing of DrugCheck® devices using processes that continue to be recognized as among the most advanced in all of rapid drugs of abuse test manufacturing
  • February: Agreement signed with Mexican distributor granting exclusive rights to distribute DrugCheck® product throughout Mexico

2004

  • October: Founding of Express Diagnostics Int’l, Inc.